Drug profile · INN
azlocillin sodium
AZLIN
azlocillin sodium (AZLIN) is a penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Drug details — azlocillin sodium
- US status
- approved
- Class
- —
- Route
- INJECTION
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
azlocillin sodium (AZLIN) is a penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
Key facts
Mechanism of action
Penicillin-binding protein inhibitor
Primary target: Penicillin-binding protein
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Congress & event coverage
- PresentationTHMA Pharmacy Growth
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is azlocillin sodium?
azlocillin sodium (AZLIN) is a penicillin-binding protein inhibitor. Route of administration: injection. Current US regulatory status: approved.
What is the brand name for azlocillin sodium?
AZLIN is a marketed brand name for azlocillin sodium. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of azlocillin sodium?
azlocillin sodium has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.